Boehringer Ingelheim achieves modest growth in the first half of 2018
Advances in research and development Half-year net sales of 8.6 billion euros Satisfactory currency-adjusted growth in all businesses Major investments in sites in Germany and France INGELHEIM, Germany, Aug. 1,…